333 related articles for article (PubMed ID: 15952966)
1. Hair loss with chemotherapy: at a loss over its management?
Randall J; Ream E
Eur J Cancer Care (Engl); 2005 Jul; 14(3):223-31. PubMed ID: 15952966
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerance of a scalp-cooling system for prevention of hair loss and the experience of breast cancer patients treated by adjuvant chemotherapy.
Protière C; Evans K; Camerlo J; d'Ingrado MP; Macquart-Moulin G; Viens P; Maraninchi D; Genre D
Support Care Cancer; 2002 Oct; 10(7):529-37. PubMed ID: 12324807
[TBL] [Abstract][Full Text] [Related]
3. A multicentre study to determine the efficacy and patient acceptability of the Paxman Scalp Cooler to prevent hair loss in patients receiving chemotherapy.
Massey CS
Eur J Oncol Nurs; 2004 Jun; 8(2):121-30. PubMed ID: 15171971
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of penguin cap as scalp cooling system for prevention of alopecia in patients undergoing chemotherapy.
Kargar M; Sarvestani RS; Khojasteh HN; Heidari MT
J Adv Nurs; 2011 Nov; 67(11):2473-7. PubMed ID: 21635283
[TBL] [Abstract][Full Text] [Related]
5. Scalp cooling for hair preservation and associated characteristics in 1411 chemotherapy patients - results of the Dutch Scalp Cooling Registry.
van den Hurk CJ; Peerbooms M; van de Poll-Franse LV; Nortier JW; Coebergh JW; Breed WP
Acta Oncol; 2012 Apr; 51(4):497-504. PubMed ID: 22304489
[TBL] [Abstract][Full Text] [Related]
6. What is wrong with the 30-year-old practice of scalp cooling for the prevention of chemotherapy-induced hair loss?
Breed WP
Support Care Cancer; 2004 Jan; 12(1):3-5. PubMed ID: 14615930
[TBL] [Abstract][Full Text] [Related]
7. Scalp cooling by cold air for the prevention of chemotherapy-induced alopecia.
Hillen HF; Breed WP; Botman CJ
Neth J Med; 1990 Dec; 37(5-6):231-5. PubMed ID: 2074916
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy-induced hair loss.
Trüeb RM
Skin Therapy Lett; 2010; 15(7):5-7. PubMed ID: 20700552
[TBL] [Abstract][Full Text] [Related]
9. Scalp cooling: management option for chemotherapy-induced alopecia.
Roe H
Br J Nurs; 2014 Sep 11-24; 23(16):S4, S6, S8 passim. PubMed ID: 25203854
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Scalp Cooling in Preventing Chemotherapy-Induced Alopecia in Breast Cancer Patients Receiving Adjuvant Docetaxel and Cyclophosphamide Chemotherapy.
Cigler T; Isseroff D; Fiederlein B; Schneider S; Chuang E; Vahdat L; Moore A
Clin Breast Cancer; 2015 Oct; 15(5):332-4. PubMed ID: 25749072
[TBL] [Abstract][Full Text] [Related]
11. Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer.
Rugo HS; Klein P; Melin SA; Hurvitz SA; Melisko ME; Moore A; Park G; Mitchel J; Bågeman E; D'Agostino RB; Ver Hoeve ES; Esserman L; Cigler T
JAMA; 2017 Feb; 317(6):606-614. PubMed ID: 28196257
[TBL] [Abstract][Full Text] [Related]
12. Impact of scalp cooling on chemotherapy-induced alopecia, wig use and hair growth of patients with cancer.
van den Hurk CJ; van den Akker-van Marle ME; Breed WP; van de Poll-Franse LV; Nortier JW; Coebergh JW
Eur J Oncol Nurs; 2013 Oct; 17(5):536-40. PubMed ID: 23571182
[TBL] [Abstract][Full Text] [Related]
13. Scalp cooling to prevent hair loss in chemotherapy.
Dougherty L
Prof Nurse; 1996 May; 11(8):507-9. PubMed ID: 8718338
[TBL] [Abstract][Full Text] [Related]
14. A narrative study of chemotherapy-induced alopecia.
Williams J; Wood C; Cunningham-Warburton P
Oncol Nurs Forum; 1999 Oct; 26(9):1463-8. PubMed ID: 11064878
[TBL] [Abstract][Full Text] [Related]
15. Impact of alopecia and scalp cooling on the well-being of breast cancer patients.
van den Hurk CJ; Mols F; Vingerhoets AJ; Breed WP
Psychooncology; 2010 Jul; 19(7):701-9. PubMed ID: 19637250
[TBL] [Abstract][Full Text] [Related]
16. [Scalp cooling for chemotherapy-induced alopecia].
Komen MM; Smorenburg CH; van den Hurk CJ; Nortier JW
Ned Tijdschr Geneeskd; 2011; 155(45):A3768. PubMed ID: 22085565
[TBL] [Abstract][Full Text] [Related]
17. The use of scalp cooling for chemotherapy-induced hair loss.
Young A; Arif A
Br J Nurs; 2016 May 26-Jun 8; 25(10):S22, S24-7. PubMed ID: 27231746
[TBL] [Abstract][Full Text] [Related]
18. A phase I study of topical Tempol for the prevention of alopecia induced by whole brain radiotherapy.
Metz JM; Smith D; Mick R; Lustig R; Mitchell J; Cherakuri M; Glatstein E; Hahn SM
Clin Cancer Res; 2004 Oct; 10(19):6411-7. PubMed ID: 15475427
[TBL] [Abstract][Full Text] [Related]
19. Anticipating an altered appearance: women undergoing chemotherapy treatment for breast cancer.
Frith H; Harcourt D; Fussell A
Eur J Oncol Nurs; 2007 Dec; 11(5):385-91. PubMed ID: 17512251
[TBL] [Abstract][Full Text] [Related]
20. 'Atrophic telogen effluvium' from cytotoxic drugs and a randomized controlled trial to investigate the possible protective effect of pretreatment with a topical vitamin D analogue in humans.
Bleiker TO; Nicolaou N; Traulsen J; Hutchinson PE
Br J Dermatol; 2005 Jul; 153(1):103-12. PubMed ID: 16029334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
